Literature DB >> 10453741

Two novel mutations in a cystic fibrosis patient of Chinese origin.

J A Wagner1, A Vassilakis, K Yee, M Li, G Hurlock, M E Krouse, R B Moss, J J Wine.   

Abstract

Cystic fibrosis is rare in non-Caucasian populations, and in such populations little is known about the spectrum of mutations and polymorphisms in the CFTR gene. We studied a 23-year-old patient of Chinese ethnicity with sweat chloride values of 104 mM/l, pancreatic sufficiency, an FEV1 60% of normal, sputum cultures positive for Staphylococcus aureus and Burkholderia cepacia, and a history of allergic bronchopulmonary aspergillosis. Genetic screening for 31 common CFTR mutations was negative, leading us to search for unknown mutations using single-strand conformation polymorphism and heteroduplex analysis (SSCP/HA). Two novel mutations were detected. In exon 4, a deletion of 8 bp (451458, deltaGCTTCCTA) causes a frameshift and immediately creates a stop codon. In exon 16, mutation 3041G-->A causes the missense change G970D. Functional analysis using an isotopic flux assay indicated that the G970D mutation retains partial function; western blotting indicated that the protein is glycosylated. The patient is heterozygous for the common polymorphisms (2694T/G) in exon 14a and (GATT)6/7 in intron 6a, indicating that these variants arose in ancestors common to Caucasians and Chinese.

Entities:  

Mesh:

Year:  1999        PMID: 10453741     DOI: 10.1007/s004390050996

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Cystic fibrosis with homozygous R553X mutation in a Taiwanese child.

Authors:  Hui-Ju Chen; Shuan-Pei Lin; Hung-Chang Lee; Chih-Ping Chen; Nan-Chang Chiu; Han-Yang Hung; Schu-Rern Chern; Chih-Kuang Chuang
Journal:  J Hum Genet       Date:  2005-11-10       Impact factor: 3.172

2.  Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases.

Authors:  Yanqiu Liu; Xiaoming Wei; Xiangdong Kong; Xueqin Guo; Yan Sun; Jianfen Man; Lique Du; Hui Zhu; Zelan Qu; Ping Tian; Bing Mao; Yun Yang
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

3.  p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis.

Authors:  Xinlun Tian; Yaping Liu; Jun Yang; Han Wang; Tao Liu; Wenbing Xu; Xue Li; Yuanjue Zhu; Kai-Feng Xu; Xue Zhang
Journal:  Hum Genome Var       Date:  2016-01-07

4.  CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis.

Authors:  Gordon K C Leung; Dingge Ying; Christopher C Y Mak; Xin-Ying Chen; Weiyi Xu; Kit-San Yeung; Wai-Lap Wong; Yoyo W Y Chu; Gary T K Mok; Christy S K Chau; Jenna McLuskey; Winnie P T Ong; Huey-Yin Leong; Kelvin Y K Chan; Wanling Yang; Jeng-Haur Chen; Albert M Li; Pak C Sham; Yu-Lung Lau; Brian H Y Chung; So-Lun Lee
Journal:  Mol Genet Genomic Med       Date:  2016-11-13       Impact factor: 2.183

5.  Clinical and genetic characteristics of cystic fibrosis in CHINESE patients: a systemic review of reported cases.

Authors:  Xiaobei Guo; Keqiang Liu; Yaping Liu; Yusen Situ; Xinlun Tian; Kai-Feng Xu; Xue Zhang
Journal:  Orphanet J Rare Dis       Date:  2018-12-17       Impact factor: 4.123

6.  Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation.

Authors:  Haiyan Li; Li Lin; Xiaoguang Hu; Changchong Li; Hailin Zhang
Journal:  Front Pediatr       Date:  2019-02-20       Impact factor: 3.418

7.  c.753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: A case report and review of the literature.

Authors:  Yu-Qing Wang; Chuang-Li Hao; Wu-Jun Jiang; Yan-Hong Lu; Hui-Quan Sun; Chun-Yan Gao; Min Wu
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

Review 8.  A review of cystic fibrosis: Basic and clinical aspects.

Authors:  Qionghua Chen; Yuelin Shen; Jingyang Zheng
Journal:  Animal Model Exp Med       Date:  2021-09-16

9.  Molecular structure of the ATP-bound, phosphorylated human CFTR.

Authors:  Zhe Zhang; Fangyu Liu; Jue Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-20       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.